Wong Linda L, Kalantar-Zadeh Kamyar, Page Victoria, Hayashida Glen, You Amy S, Rhee Connie M
Department of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii.
Am J Nephrol. 2017;45(3):200-208. doi: 10.1159/000455389. Epub 2017 Jan 27.
The value of chronic kidney disease (CKD) screening in the general population remains unclear but may be beneficial in populations with high disease prevalence. We examined risk factors for albuminuria among participants in a state-wide CKD screening program in Hawaii.
The National Kidney Foundation of Hawaii Kidney Early Detection Screening (NKFH-KEDS) program held 19 CKD screening events from 2006 to 2012. Participants rotated through 5 stations during which sociodemographic, blood glucose, urine albumin-to-creatinine ratio (ACR), and spot urine albumin data were collected. Multivariate logistic regression analyses (adjusted for age, sex, race/ethnicity, body mass index [BMI]) were used to identify clinical predictors of abnormal ACR (≥30 μg/mg) and abnormal spot urine albumin (>20 mg/L) levels.
Among 1,190 NKFH-KEDS participants who met eligibility criteria, 13 and 49% had abnormal ACR and urine albumin levels, respectively. In multivariate logistic regression analyses, participants of older age (>65 years), Asian and Pacific Islander race/ethnicity, BMI ≥30 kg/m2, and with hypertension had higher risk of abnormal ACR. Being of older age; Asian, Pacific Islander, and Mixed race/ethnicity; and having diabetes was associated with higher risk of abnormal urine albumin levels in adjusted analyses.
NKFH-KEDS participants of older age; Asian and Pacific Islander race/ethnicity; and with obesity, hypertension, and diabetes had higher risk of kidney damage defined by elevated ACR and urine albumin levels. Further studies are needed to determine whether targeted screening programs can result in timely identification of CKD and implementation of interventions that reduce cardiovascular disease, death, and progression to end-stage renal disease.
慢性肾脏病(CKD)在普通人群中的筛查价值尚不清楚,但在疾病患病率高的人群中可能有益。我们在夏威夷全州范围的CKD筛查项目中研究了参与者蛋白尿的危险因素。
夏威夷肾脏基金会肾脏早期检测筛查(NKFH-KEDS)项目在2006年至2012年期间举办了19次CKD筛查活动。参与者依次通过5个站点,在此期间收集社会人口统计学、血糖、尿白蛋白与肌酐比值(ACR)以及随机尿白蛋白数据。采用多因素逻辑回归分析(校正年龄、性别、种族/民族、体重指数[BMI])来确定ACR异常(≥30μg/mg)和随机尿白蛋白异常(>20mg/L)水平的临床预测因素。
在1190名符合入选标准的NKFH-KEDS参与者中,分别有13%和49%的人ACR和尿白蛋白水平异常。在多因素逻辑回归分析中,年龄较大(>65岁)、亚洲及太平洋岛民种族/民族、BMI≥30kg/m2以及患有高血压的参与者ACR异常风险较高。在校正分析中,年龄较大、亚洲、太平洋岛民及混血种族/民族以及患有糖尿病与尿白蛋白水平异常风险较高相关。
年龄较大、亚洲及太平洋岛民种族/民族以及患有肥胖症、高血压和糖尿病的NKFH-KEDS参与者因ACR和尿白蛋白水平升高而出现肾脏损害的风险较高。需要进一步研究以确定针对性筛查项目是否能及时识别CKD并实施可降低心血管疾病、死亡以及进展至终末期肾病的干预措施。